α1,2-Fucosylated and β-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer

Glycobiology

Volumn 20, Issue 4, 2009, Pages 452-460

  Fukushima, Keiko ^a   Satoh, Takefumi ^b   Baba, Shiro ^b   Yamashita, Katsuko ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glycosyltransferase; Lectin; Prostate cancer; Prostate specific antigen

Indexed keywords

AGGLUTININ; BETA N ACETYLGALACTOSAMINE; BETA N ACETYLGALACTOSAMINYLTRANSFERASE; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 1; FUCOSYLTRANSFERASE GALACTOSE; GLYCAN; LECTIN; N ACETYLGALACTOSAMINE; N ACETYLGALACTOSAMINYLTRANSFERASE; PROSTATE SPECIFIC ANTIGEN; TRICHOSANTHES JAPONICA AGGLUTININ II; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; GALACTOSYLGALACTOSYLGLUCOSYLCERAMIDE BETA D ACETYLGALACTOSAMINYLTRANSFERASE; GALACTOSYLGALACTOSYLGLUCOSYLCERAMIDE BETA-D-ACETYLGALACTOSAMINYLTRANSFERASE; POLYSACCHARIDE;

ARTICLE; CANCER CELL CULTURE; CARBOHYDRATE ANALYSIS; CARCINOGENESIS; CELL STRAIN LNCAP; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEMINAL PLASMA; BLOOD; CHEMISTRY; CHROMATOGRAPHY; METABOLISM; POLYMERASE CHAIN REACTION; PROSTATE TUMOR; SPERM;

JAPONICA; TRICHOSANTHES;

BIOLOGICAL MARKERS; CHROMATOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LECTINS; MALE; N-ACETYLGALACTOSAMINYLTRANSFERASES; POLYMERASE CHAIN REACTION; POLYSACCHARIDES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SEMEN;

EID: 77952299239     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwp197     Document Type: Article

References (43)

1. Bélanger A, van Halbeek H, Graves HC, Grandbois K, Stamey TA, Huang L, Poppe I, Labrie F. 1995. Molecular mass and carbohydrate structure of prostate specific antigen: Studies for establishment of an international PSA standard. Prostate. 27:187-197.
2. Bezouška K, Táborský O, Kubrycht J, Pospíšl M. 1985. Carbohydrate-structuredependent recognition of desialylated serum glycoproteins in the liver and leucocytes. Biochem J. 227:345-354.
3. Brawer MK, Meyer GE, Letran JL, Bankson DD, Morris DL, Yeung KK, Allard WJ. 1998. Measurement of complexed PSA improves specificity for early detection of prostate cancer. Urology. 52(3):372-378.
4. Catalona WJ, Smith DS, Ornstein DK. 1997. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA. 277(18):1452-1455.
5. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB. 1995. Evaluation of percentage of free serum prostatespecific antigen to improve specificity of prostate cancer screening. JAMA. 274(15):1214-1220.
6. Christensson A, Laurell CB, Lilja H. 1990. Enzymatic activity of prostatespecific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem. 194:755-763.
7. Cuatrecasas P, Anfinsen CB. 1971. Affinity chromatography. In: Jakohy WB, editor. Methods in Enzymology. New York: Academic. Vol. 22. p. 345-78.
8. Do KY, Do S, Cummings RD. 1997. Differential expression of LacdiNAc sequences (GalNAcß1-4GlcNAc-R) in glycoproteins synthesized by Chinese hamster ovary and human 293 cells. Glycobiology. 7(2):183-194.
9. Fukushima K, Hara-Kuge S, Seko A, Ikehara Y, Yamashita K. 1998. Elevation of α2-6 sialyltransferase and α1-2 fucosyltransferase activities in human choriocarcinoma. Cancer Res. 58:4301-4306.
10. Fukushima K, Ohkura T, Kanai M, Kuroki M, Matsuoka Y, Kobata A, Yamashita K. 1995. Carbohydrate structures of a normal counterpart of the carcinoembryonic antigen produced by colon epithelial cells of normal adults. Glycobiology. 5:105-115.
11. Gotoh M, Sato T, Kiyohara K, Kameyama A, Kikuchi N, Kwon YD, Ishizuka Y, Iwai T, Nakanishi H, Narimatsu H. 2004. Molecular cloning and characterization of b1,4-N-acetylgalactosaminyltransferases IV synthesizing N, N′diacetyllactosediamine. FEBS Lett. 562:134-140.
12. Hindsgaul O, Norberg T, Le Pendu J, Lemieux RU. 1982. Synthesis of type 2 human blood-group antigenic determinants. The H, X and Y haptens and variations of the H type 2 determinant as probes for the combining site of the lectin I of Ulex europaeus. Carbohydr Res. 109:109-142.
13. Jaques AJ, Opdenakker G, Rademacher TW, Dwek RA, Zamze SE. 1996. The glycosylation of Bowes melanoma tissue plasminogen activator: Lectin mapping, reaction with anti-L2/HNK-1 antibodies and the presence of sulphated/glucuronic acid containing glycans. Biochem J. 316:427-437.
14. Kannagi R, Fukushi Y, Tachikawa T, Noda A, Shin S, Shigeta K, Hiraiwa N, Fukuda Y, Inamoto T, Hakomori S, et al. 1986. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Cancer Res. 46:2619-2626.
15. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. 1995. Sequence and expression of a candidate for the human secretor blood group a(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzymeinactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem. 270:4640-4649.
16. Kornfeld K, Reitman ML, Kornfeld R. 1981. The carbohydrate-binding specificity of pea and lentil lectins: Fucose is an important determinant. J Biol Chem. 256:6633-6640.
17. 1H-NMR spectroscopy and deglycosylation by N-glycanase. Eur J Biochem. 197:209-215.
18. Larsen RD, Ernst LK, Nair RP, Lowe JB. 1990. Molecular cloning, sequence, and expression of a human GDP-L-fucose:b-D-galactoside 2-α-L-fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci USA. 87:6674-6678.
19. Lilja H, Christensson A, Dahlén U, Matikainen MT, Nilsson O, Pettersson K, Lövgren T. 1991. Prostate-specific antigen in serum occurs predominantly in complex with α1-antichymotrypsin. Clin Chem. 37:1618-1625.
20. Lundwall A, Lilja H. 1987. Molecular cloning of human prostate specific antigen cDNA. FEBS Lett. 214:317-322.
21. Matsumoto K, Satoh T, Egawa S, Shimura S, Kuwao S, Baba S. 2005. Efficacy and morbidity of transrectal ultrasound-guided 12-core biopsy for detection of prostate cancer in Japanese men. Int J Urol. 12:353-360.
22. Montiel MD, Krzewinski-Recchi MA, Delannoy P, Harduin-Lepers A. 2003. Molecular cloning, gene organization and expression of the human UDP-GalNAc:Neu5Aca2-3Galb-R b1,4-N-acetylgalactosaminyltransferase responsible for the biosynthesis of the blood group Sda/Cad antigen: Evidence for an unusual extended cytoplasmic domain. Biochem J. 373:369- 379.
23. Ohkura T, Seko A, Hara-Kuge S, Yamashita K. 2002. Occurrence of secretory glycoprotein-specific GalNAc b1-4GlcNAc sequence in N-glycans in MDCK cells. J Biochem. 132:891-901.
24. Ohyama C, Hosono M, Nitta K, Oh-eda M, Yoshikawa K, Habuchi T, Arai Y, Fukuda M. 2004. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Glycobiology. 14:671-679.
25. Okada T, Sato Y, Kobayashi N, Sumida K, Satomura S, Matsuura S, Takasaki M, Endo T. 2001. Structural characteristics of the N-glycans of two isoforms of prostate-specific antigens purified from human seminal fluid. Biochim Biophys Acta. 1525:149-160.
26. Okihara K, Babaian RJ. 2001. Early detection of prostate cancer: Is PSA a reliable option? Tex Med. 97(2):59-62.
27. Peracaula R, Tabarés G, Royle L, Harvey DJ, Dwek RA, Rudd PM, de Llorens R. 2003. Altered glycosylation pattern allows the distinction between prostate specific antigen (PSA) from normal and tumor origins. Glycobiology. 13:457-470.
28. Prakash S, Robbins PW. 2000. Glycotyping of prostate specific antigen. Glycobiology. 10:173-176.
29. Sato T, Gotoh M, Kiyohara K, Kameyama A, Kubota T, Kikuchi N, Ishizuka Y, Iwasaki H, Togayachi A, Kudo T, et al. 2003. Molecular cloning and characterization of a novel human b1,4-N-acetylgalactosaminyltransferase, b4GalNAc-T3, responsible for the synthesis of N, N′-diacetyllactosediamine, GalNAc b1-4GlcNAc. J Biol Chem. 278:47534-47544.
30. Satoh T, Matsumoto K, Fujita T, Tabata K, Okusa H, Tsuboi T, Arakawa T, Irie A, Egawa S, Baba S. 2005. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology. 66:114-118.
31. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. 1987. Prostatespecific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 317:909-916.
32. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. 1991. A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res. 51:222-226.
33. Sumi S, Arai K, Kitahara S, Yoshida K. 1999. Serial lectin affinity chromatography demonstrates altered asparagine-linked sugar-chain structures of prostate-specific antigen in human prostate carcinoma. J Chromatogr B Biomed Sci Appl. 727:9-14.
34. Tajiri M, Ohyama C, Wada Y. 2008. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: A glycopeptides approach. Glycobiology. 18:2-8.
35. Takashima S, Tsuji S, Tsujimoto M. 2002. Characterization of the second type of human b-galactoside a2,6-sialyltransferase (ST6Gal II), which sialylates Galb1,4GlcNAc structures on oligosaccharides preferentially. Genomic analysis of human sialyltransferase genes. J Biol Chem. 277:45719-45728.
36. Uchida Y, Tsukada Y, Sugimori T. 1974. Production of microbial neuraminidases induced by colominic acid. Biochim Biophys Acta. 350:425-431.
37. Wang WC, Cummings RD. 1988. The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex-type Asnlinked oligosaccharides containing terminal sialic acid-linked a-2,3 to penultimate galactose residues. J Biol Chem.263:4576-4585.
38. Yamashita K, Kobata A. 1996a. Hepatocellular carcinoma. In: Montreuil J, Schachter H, Vliegenthart JFG, editors. Glycoproteins and Disease. Amsterdam: Elsevier. p. 197-210.
39. Yamashita K, Kobata A. 1996b. Carcinoembryonic antigen and related normal antigens. In: Montreuil J, Schachter H, Vliegenthan JFG, editors. Glycoproteins and Disease. Amsterdam: Elsevier. p. 229-39.
40. Yamashita K, Koide N, Endo T, Iwaki Y, Kobata A. 1989. Altered glycosylation of serum transferring of patients with hepatocellular carcinoma. J Biol Chem. 264:2415-2423.
41. Yamashita K, Ohkura T, Umetsu K, Suzuki T. 1992b. Purification and characterization of a Fuca1→2Galbl→ and GalNAcbl→ specific lectin in root tubers of Trichosanthes japonica. J Biol Chem. 267:25414-25422.
42. -→6 Galbl→4GlcNAc specific lectin in tuberous roots of Trichosanthes japonica. Biochemistry. 31:11647-11650.
43. Yamashita K, Totani K, Ohkura T, Takasaki S, Goldstein IJ, Kobata A. 1987. Carbohydrate binding properties of complex-type oligosaccharides on immobilized Datura stramonium leclin. J Biol Chem. 262:1602-1607.